Navigation Links
Merz research Shows Long-term Benefits for Patients With Dystonia
Date:10/21/2011

FRANKFURT AM MAIN, Germany, October 21, 2011 /PRNewswire/ --

At the 5th International Dystonia Symposium (IDS) in Barcelona, Spain (20-22 October 2011), Merz Pharmaceuticals presented important clinical data concerning the long-term, sustained efficacy and safety of XEOMIN® for the treatment of patients with dystonia.

Dystonia is a particularly debilitating condition where involuntary muscle contractions can cause abnormal twisting, postures or movements, and is the third most common movement disorder after essential tremor and Parkinson's disease.[1] New data presented at recent neurological congresses and summarized at the IDS indicate that patients treated with XEOMIN® for cervical dystonia or blepharospasm (involuntary closing of the eyelids) experienced long-term sustained efficacy with a favorable safety profile in studies of up to 121 and 88 weeks duration, respectively.[2-4] Furthermore, the incidence of adverse events decreased with each injection session, indicating no cumulative effect of the drug with repeated treatments.[2,4] Professor Alberto Albanese from the Istituto Neurologico Carlo Besta, Milan, Italy, who is the lead author of the recently published new European Federation of Neurological Societies guidelines on the diagnosis and treatment of dystonia,[5] stated that "Botulinum neurotoxin type A should be regarded as the first-line treatment for patients with dystonia. It is also important to know that repeated treatments are safe and efficacious over many years. These data give physicians more confidence in using this medication over the long term".

Professor Alberto Albanese indicated that "most patients with dystonia require long-term treatment. Moreover flexibility is needed with respect to time interval between treatment sessions to facilita
'/>"/>

SOURCE Merz Pharmaceuticals GmbH
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Critical Alerts For Intel, Mosaic, Deckers, Foot Locker, and Jazz Pharmaceuticals Released By Seven Summits Research
2. Bend Research Announces New Chief Financial Officer
3. SANYO Offers Researchers Energy-Efficient, Space-Saving Solutions for Biological Sample Preservation
4. Clinical Research Sites Honor Top Sponsor, CRO and IRB at 2011 Site Solutions Summit
5. VaxyGen Manufacturing Services LLC Announces Exclusive License and Collaborative Agreement with Georgia State University Research Foundation to Commercialize Novel Biological Process Development Patent, Expertise & Know-How
6. SomaLogic Announces Research Agreement with Leading Global Pharmaceutical Company to Accelerate Pharmaceutical Discovery and Development
7. Rock Creek Pharmaceuticals Announces Expanded International Shipping Options for Anatabloc™, Physician Conferences on Anatabine Research
8. Aethlon Medical Announces Availability of its Exosome Detection Assay to the Research Community
9. Bend Research Announces Schedule of Events at 2011 AAPS Annual Meeting and Exposition
10. VisionSpring Research Finds Seeing to be the Most Important of Five Senses
11. Techstreet and the ISPE Extend Partnership to Expedite Drug Research with Subscription Offering for Life Science Engineers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... PARK, N.J. , July 30, 2015  Unichem ... voluntarily recalling one lot of Hydrochlorothiazide tablets 25 mg ... been initiated as a precautionary measure due to the ... of the product. The risk associated ... Hydrochlorothiazide tablet is the increased probability of experiencing Clopidogrel,s ...
(Date:7/30/2015)... July 30, 2015 PTC Therapeutics, Inc. (NASDAQ: ... reported financial results for the second quarter ending June ... many fronts across the organization.  We are excited to ... dystrophy clinical trial ever conducted with topline results expected ... Chief Executive Officer, PTC Therapeutics, Inc. "Translarna is now ...
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... 2015 keynote address last month that industry is compelled ... order to gain the efficiencies—and develop the transformational innovations ... Dr. Barsoum,s comments were preceded by Doug Kohrs ... and OMTEC moderator, who stressed that industry must add ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... MUNDELEIN, Ill. , July 1 ... and information systems developer, today announces executive changes in ...  John Kershaw, President & CEO, Sysmex America Inc. has ... Secretary; Judy Bosko as Vice President of ...
... SCHAUMBURG, Ill. , July 1 ... today announced that the U.S. Food and Drug Administration ... sodium injection, USP. Heparin is a vital anticoagulant, preventing ... within the blood, routinely used in surgical and dialysis ...
Cached Medicine Technology:Sysmex America Announces Executive Leadership Changes 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 3FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 4
(Date:8/1/2015)... CT (PRWEB) , ... August 01, 2015 , ... On March 19, 2015 Phil Valentine ... mile trek of the Appalachian Trail by stepping off Springer Mountain and heading ... , On July 26th Phil reached Connecticut and was greeted by friends and family. ...
(Date:7/31/2015)... CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 will ... National Football League’s biggest day each year is the Super Bowl. In the two weeks ... takes place from the host venue. The 2016 Super Bowl game will mark the 50th ...
(Date:7/31/2015)... ... ... The 2nd annual Ride to Fight On will start and end near the ... to Fight On is a cycling fundraiser that benefits the West Cancer Center, a ... University of Tennessee Health Science Center. A health and wellness festival featuring food, music, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Coco Libre announced today that their flagship ... at the 2015 Vans US Open of Surfing, July 25 through August 2 in ... added sugar” on the market, is a natural choice given the Open’s commitment to ...
(Date:7/31/2015)... ... , ... Well-known for its unique pastries and delicious confections, Pastry Palace, a ... making life just a little bit sweeter for newlyweds. A family-owned business, the Pastry ... one. , The bakery provides a full line of custom wedding cakes. Brides can ...
Breaking Medicine News(10 mins):Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2
... Inc. (Nasdaq: OSTE ), a leader in ... announced today that the Company,s fourth quarter and full ... released Wednesday, March 4, 2009. The management team of ... Thursday, March 5, 2009, at 9:00 a.m. (EST) to ...
... March 2 At Aurora Health Care , finding ... businesses that rely on the health care provider for health ... well-being of its own employees, and that commitment recently was ... its local affiliate the Wellness Council of Wisconsin, presented its ...
... March 2 Speaker Nancy Pelosi released the ... Kathleen Sebelius as Secretary of the Department of Health ... bipartisan leader who has worked to expand health care ... prescription drugs. "Governor Sebelius, deep understanding of health care ...
... March 2 Nitinol Devices & Components, Inc. ... novel medical device anchoring technology from Phase One ... This anchoring technology integrates the superelastic material properties ... provide secure fixation and removability for minimally invasive ...
... cites association on GMPs and adverse event reportingWASHINGTON, ... the U.S. Government Accountability Office (GAO) of a ... supplements, the Natural Products Association (NPA) released the ... Seckman."The Natural Products Association appreciates having the opportunity ...
... 2 /PRNewswire-Asia-FirstCall/ -- China Nepstar,Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based on the number of ... the fourth quarter and,fiscal year 2008 financial results ended ... 16, 2009. , The Company ...
Cached Medicine News:Health News:Aurora Wins Gold Well Workplace Award for Commitment to Employee Health and Well-Being 2Health News:NDC Completes Acquisition of Phase One Medical(R) Anchoring Technology 2Health News:Natural Products Association Comments on New GAO Report on Regulation of Dietary Supplements 2Health News:China Nepstar Chain Drugstore to Announce Fourth Quarter and Fiscal 2008 Financial Results on March 16 2
The Vitatron Slimtine S lead series are endocardial leads with an excellent history of reliability and optimal handling en pacing performance....
Unipolar Atrial "J" Lead...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: